The United States of America; Department of Health and Human Servic; as represented by the Secretary
发明人:
Irving W. Wainer,Michel Bernier,Rajib K. Paul
申请号：
US16600234
公开号：
US20200030261A1
申请日:
2019.10.11
申请国别(地区):
US
年份:
2020
代理人:
摘要：
This disclosure concerns the discovery of the use of fenoterol analogues for regulating cannabinoid (CB) receptor activity-related disorders and disease, such as dysregulated CB receptors, including treating a disorder or disease, such as a glioblastoma, hepatocellular carcinoma, liver cancer, colon cancer, and/or lung cancer, which is associated with altered cannabinoid receptor activity. In one example, the method includes administering to a subject having or at risk of developing a disorder or disease regulated by CB receptor activity an effective amount of a fenoterol analogue to reduce one or more symptoms associated with the disorder or disease regulated by CB receptor activity.
